Crow Point Partners »

Recro Pharma shares owned by Crow Point Partners

Quarter-by-quarter ownership of Recro Pharma (SCTL) shares owned by Crow Point Partners from 13F filings

Historical chart of Crow Point Partners investment in Recro Pharma

Tip: Access up to 7 years of quarterly data

All positions including Recro Pharma held by Crow Point Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Recro Pharma by Crow Point Partners

Quarter filed Position value Share count Share price at filing
2019-12-31 $792k 42k 18.81

More positions owned by Crow Point Partners

iShares S&P MidCap 400 Index (IJH)
Spdr Bloomberg Barclays High Yield Bond Etf etf (JNK)
iShares S&P Natl AMTFr Mncpl Bd (MUB)
iShares Barclays 20+ Yr Treas.Bond (TLT)
iShares Lehman Aggregate Bond (AGG)
iShares MSCI Netherlands Investable (EWN)
Vaneck Vectors J.p. Morgan Em Local Currency Bond Etf etf (EMLC)
Ishares Inc emrg mrk lc bd (LEMB)
Royce Value Trust (RVT)
Spdr S&p 500 Etf (SPY)
Ishares Tr core msci pac (IPAC)
Tesla Motors (TSLA)
iShares MSCI Germany Index Fund (EWG)
iShares Russell 2000 Growth Index (IWO)
Eaton Vance Limited Duration Income Fund (EVV)

View all positions for Crow Point Partners

Top funds holding Recro Pharma

First Light Asset Management
AWM Investment Company
Royce & Associates
Samjo Management
Vanguard Group
OV Management
Caligan Partners
Alyeska Investment Group
Nantahala Capital Management
Crystalline Management
BlackRock
Clear Harbor Asset Management
FNY Investment Advisers
Titleist Asset Management
Citadel Advisors

View all funds holding Recro Pharma